BiotechTube
Home/Antabio/Dr. Erick Lelouche
DE

Dr. Erick Lelouche

Chairman of the Board

Antabio

Therapeutic Areas

Infectious DiseaseRespiratory Diseases

Antabio Pipeline

DrugIndicationPhase
Meropenem-Pilabactam (MEM-PIL)HABP/VABP, Bloodstream Infections (BSI)Phase 2
PEi (Pseudomonas aeruginosa elastase inhibitor)Chronic Respiratory DiseasesDiscovery
Novel Target / Novel Chemical SeriesOral/IV, Nosocomial InfectionsDiscovery
Novel Target 2Oral/IV, Nosocomial InfectionsDiscovery